ValuEngine Downgrades STRATA Skin Sciences (NASDAQ:SSKN) to Hold

ValuEngine lowered shares of STRATA Skin Sciences (NASDAQ:SSKN) from a buy rating to a hold rating in a report issued on Thursday, ValuEngine reports.

SSKN has been the subject of several other research reports. Northland Securities reissued a buy rating and set a $7.00 price target on shares of STRATA Skin Sciences in a research report on Tuesday, May 14th. HC Wainwright set a $5.00 target price on shares of STRATA Skin Sciences and gave the stock a buy rating in a research report on Monday, July 8th. Finally, Zacks Investment Research cut shares of STRATA Skin Sciences from a buy rating to a hold rating in a research report on Saturday, June 1st. Two equities research analysts have rated the stock with a hold rating and three have given a buy rating to the company. The stock presently has an average rating of Buy and a consensus target price of $4.92.

SSKN traded up $0.08 during trading on Thursday, hitting $2.92. 14,800 shares of the stock traded hands, compared to its average volume of 46,199. The company has a 50-day moving average price of $2.49. STRATA Skin Sciences has a 12-month low of $1.86 and a 12-month high of $3.88.

Large investors have recently bought and sold shares of the company. Virtu Financial LLC purchased a new stake in shares of STRATA Skin Sciences in the 1st quarter worth about $39,000. Northern Trust Corp purchased a new stake in shares of STRATA Skin Sciences in the 4th quarter worth about $36,000. Creative Planning lifted its position in shares of STRATA Skin Sciences by 42.9% in the 2nd quarter. Creative Planning now owns 50,000 shares of the medical device company’s stock worth $125,000 after purchasing an additional 15,000 shares during the period. Finally, Meitav Dash Investments Ltd. lifted its position in shares of STRATA Skin Sciences by 12.8% in the 1st quarter. Meitav Dash Investments Ltd. now owns 807,234 shares of the medical device company’s stock worth $2,314,000 after purchasing an additional 91,418 shares during the period. 30.93% of the stock is owned by hedge funds and other institutional investors.

STRATA Skin Sciences Company Profile

STRATA Skin Sciences, Inc, a medical technology company, focuses on the therapeutic and aesthetic dermatology market. The company operates through three segments: Dermatology Recurring Procedures, Dermatology Procedures Equipment, and Dermatology Imaging. Its products include XTRAC laser and VTRAC excimer lamp systems used for the treatment of psoriasis, vitiligo, and other skin conditions; the STRATAPEN MicroSystems, a micropigmentation device; and Nordlys, a multi-technology aesthetic laser device for treating vascular and pigmented lesions.

Featured Article: Roth IRA

To view ValuEngine’s full report, visit ValuEngine’s official website.

Receive News & Ratings for STRATA Skin Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for STRATA Skin Sciences and related companies with MarketBeat.com's FREE daily email newsletter.